Imiquimod Cream
Product Images NDC 87519-004

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 87519-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anvi Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table-2 (Table 2.)

Data table presenting the incidence and severity of various skin reactions in clinical studies comparing Imiquimod Cream 3.75% and 2.5% versus vehicle. The table details percentages of all grades and severe occurrences for conditions such as erythema, scabbing/crusting, flaking/scaling/dryness, edema, erosion/ulceration, and exudate across groups of 160, 160, and 159 subjects respectively.*

FDA Label Image

Table-3 (Table 3.)

Data table presenting adverse reactions comparing Imiquimod Cream 3.75% (N=400) and vehicle (N=202). Lists application site pain, irritation, pruritus, bacterial vaginitis, and headache with the number and percentage of occurrences for each treatment group.*

FDA Label Image

Table-4 (Table 4.)

A table comparing the incidence of skin reactions between Imiquimod Cream, 3.75% (N=400) and Vehicle (N=202). It shows percentages for Erythema, Edema, Erosion/ulceration, and Exudate, including severe cases, across both groups.*

FDA Label Image

Pump (Bottle Pump Label)

Label for Imiquimod Cream USP 3.75% topical pump, 7.5 g net weight, manufactured by Anvi Pharmaceuticals Inc. The label includes storage instructions, usage warnings restricting to topical use only, and a barcode. It also notes the product delivers no fewer than 28 full actuations per pump.*

FDA Label Image

Carton (Carton Label)

Imiquimod Cream USP 3.75% topical cream in a 7.5 g pump bottle package. Label shows the product name, strength, dosage form, and directions for use including storage instructions and warnings. Manufacturer is Anvi Pharmaceuticals Inc., Princeton, NJ. The packaging includes barcodes and the NDC 87519-004-75.*

FDA Label Image

Chemical Structure (Imiquimod 01)

Chemical structure diagram of the active ingredient Imiquimod, showing its molecular framework with labeled atoms and bonds.*

FDA Label Image

Figure 1 (Imiquimod 02)

A line graph showing cumulative complete clearance over weeks for Imiquimod 3.75% cream versus vehicle. The graph compares the effectiveness of Imiquimod 3.75% to the vehicle over a 16-week period, illustrating greater clearance with Imiquimod.*

FDA Label Image

P (Imiquimod 03)

A black and white line drawing illustrating a hand holding and using a topical cream tube. The index finger is pressing on the tube's applicator tip, shown being squeezed to dispense cream. This instructional figure likely demonstrates proper application technique for a topical cream product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.